Figure Technology Solutions enters the week down 25% over the past month, and a steady stream of insider selling across that same window makes the pullback harder to dismiss as purely technical.
The insider angle is the most striking feature of this setup. Both the CEO and CFO have been active sellers. CEO Michael Tannenbaum sold roughly 17,000 shares across two days in mid-May at prices around $37–$38, collecting just over $627,000. CFO Macrina Kgil followed with three separate transactions on May 26 and another sale on June 2, selling close to 31,000 shares at prices ranging from $32 to $37 for a combined take of around $1 million. A chief-level officer also offloaded more than 28,000 shares around May 14 as the stock briefly touched the low $40s. The net 90-day insider position is technically positive — roughly 531,000 net shares — but that is almost entirely explained by compensation-related grants rather than open-market buying, and the consistent selling at successively lower prices paints a more cautious picture.
Borrow conditions do not add much pressure to the short side. Short interest has nudged up roughly 26% over the past month to 5.5% of the free float, a level that is meaningful but not extreme. At the same time, availability in the lending market is running at about 258%, well above the 100% threshold where supply starts to feel tight, and borrowing costs have drifted down to around 0.49% — less than half their late-April level. The ORTEX short score of 52 has been drifting gently higher through June but remains mid-range. Taken together, the lending market is comfortable: shorts face no squeeze pressure, and new positions can be established cheaply.
Options positioning is mildly more defensive than recent norms, but not alarmingly so. The put/call ratio is running at 0.46, slightly above its 20-day average of 0.43 and about 0.9 standard deviations above the mean — a modest tilt toward hedging rather than a pronounced fear signal. Worth noting is that a year ago the PCR touched 1.17, so the current reading leaves substantial room before options traders would be flagging real distress. The more meaningful observation is that call-heavy positioning dominated through much of May, when the stock was higher; that enthusiasm has cooled alongside the price decline.
The Street remains constructive on paper, though the gap between targets and reality has widened sharply. The mean analyst price target is $53.63 against a current price of $28.28 — implying roughly 90% upside — but that premium reflects a chorus of Outperform and Buy ratings that were set when the stock was trading materially higher. Mizuho's Dan Dolev raised his target to $55 in mid-May after an earlier cut, and Needham reiterated Buy at $55 around the same time. Goldman Sachs cut to $44 in early March, and Bernstein trimmed to $67 from $72 in late March. The direction of travel through Q1 was broadly lower targets maintained alongside unchanged positive ratings — a pattern that signals the Street still sees long-term value but is marking down near-term expectations. The bull case centres on Figure's blockchain-enabled HELOC platform and structural cost advantages; the bear case is that HELOC volumes cool and newer products like crypto-backed loans and stablecoin deposits fail to scale quickly enough to compensate. On valuation, the PE has compressed to roughly 22x from around 32x a month ago — a meaningful de-rating — while EV/EBITDA has drifted lower as well, giving bulls slightly more to work with on multiples. Earnings momentum scores remain strong, ranking in the 88th–90th percentile on 30- and 90-day windows, which suggests estimate revisions are still moving in the right direction even as the stock falls.
Among closely correlated peers, the week was broadly weak: UPST fell 4% and SOFI lost 7%, while DFDV was the notable laggard at -16%. LC was the one exception, closing the week up about 0.8%. FIGR's -12% week sits in the middle of a sector that is broadly under pressure, which removes some of the stock-specific alarm but does not fully explain why insiders were selling at prices 20–30% above where the stock trades today.
The next scheduled earnings event falls on August 10. Between now and then, the key question is whether insider selling continues at current prices — a further cluster of transactions closer to $28 would carry a meaningfully different signal than sales executed at $36–$43.
See the live data behind this article on ORTEX.
Open FIGR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
